Jagsonpal Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹586Day's Price Range₹664.4552 Week's Low
52 Week's High
₹273.652-Week Price Range₹820.1
| Returns % | |
| 1 Month Return | -12.94 % |
| 3 Month Return | + 54.39 % |
| 1 Year Return | + 62.41 % |
| Market Stats | |
| Previous Close | ₹639.65 |
| Open | ₹643.95 |
| Volume | 1.68L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,698.01Cr |
Jagsonpal Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Market Cap | ₹1,698.01 Cr |
| P/B Ratio | 3.95 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 12.97 |
Jagsonpal Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,698.01 Cr | 481.69% | 0.52 | NA | NA | |
| NA | ₹541.66 Cr | 917.12% | 0.53 | NA | NA | |
| NA | ₹242.79 Cr | 118.19% | 0.52 | ₹16 Cr | ₹108 Cr | |
| NA | ₹47.28 Cr | 15.33% | 0.51 | ₹1 Cr | ₹62 Cr | |
| NA | ₹533.21 Cr | 12.33% | 0.66 | ₹17 Cr | ₹367 Cr |
About Jagsonpal Pharmaceuticals Ltd
Share Price: ₹598.05 per share as on 30 Dec, 2024 04:01 PM
Market Capitalisation: ₹1,698.01Cr as of today
Listing date: 13 Sep, 1996
Chairperson Name: Harsha Raghavan
| Organisation | Jagsonpal Pharmaceuticals Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals Announces Stock Split Record Date - 18 Dec, 2024
Jagsonpal Pharmaceuticals has set January 8, 2025, as the record date for a stock split, converting one equity share of Rs. 5 into multiple shares of Rs. 2 each.Jagsonpal Pharma Shows Strong Bullish Momentum - 24 Nov, 2024
Jagsonpal Pharma experienced a 19.5% rise over the week, with a notable 7.6% increase on Friday. The stock has broken out of a Rounding Bottom pattern and is retesting the neckline. A decisive breakout above Rs 655 could lead to a rally towards Rs 700, provided the support at Rs 629 holds.Sebi Penalizes Individuals for Jagsonpal Insider Trading - 23 Nov, 2024
Sebi has taken strict action against Maneesh Kumar Jain and former CFO S V Subha Rao for insider trading in Jagsonpal Pharmaceuticals, imposing fines totaling Rs 25 lakh and requiring Jain to return Rs 31.39 lakh plus interest.
Insights on Jagsonpal Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, JAGSNPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 0.00% to 0.11% in Sep 2024 quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, JAGSNPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.10% to 2.30% in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 30.01% to 29.62% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, JAGSNPHARM stock has moved down by -12.9%
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 68.04% to 67.97% in Sep 2024 quarter
Jagsonpal Pharmaceuticals Ltd Financials
Jagsonpal Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 67.97% | ||
| Foreign Institutions | 2.3% | 107.72 | |
| Mutual Funds | 0.11% | 27800.00 | |
| Retail Investors | 29.62% | ||
| Others | 0% |
Jagsonpal Pharmaceuticals Ltd Key Indicators
Jagsonpal Pharmaceuticals Ltd Earnings and Dividends
Jagsonpal Pharmaceuticals Ltd Earnings Results
Jagsonpal Pharmaceuticals Ltd’s net profit jumped 53.41% since last year same period to ₹11.46Cr in the Q2 2024-2025. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated 115.01% jump in its net profits since last 3-months.
Read More about Earnings ResultsJagsonpal Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Jagsonpal Pharmaceuticals Ltd has declared dividend of ₹5 - translating a dividend yield of 1.67%.
Read More about Dividends
Jagsonpal Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Jagsonpal Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Jagsonpal Pharmaceuticals Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Jagsonpal Pharmaceuticals Ltd shares.
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) share price today is ₹598.05
Jagsonpal Pharmaceuticals Ltd is listed on NSE
Jagsonpal Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Jagsonpal Pharmaceuticals Ltd is ₹664.45.
- Today’s lowest price of Jagsonpal Pharmaceuticals Ltd is ₹586.
Today’s traded volume of Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) is 1.68L.
Today’s market capitalisation of Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) is ₹1698.01Cr.
| Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM | Price |
|---|---|
52 Week High | ₹820.1 |
52 Week Low | ₹273.6 |
Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) share price is ₹598.05. It is down -27.08% from its 52 Week High price of ₹820.1
Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) share price is ₹598.05. It is up 118.59% from its 52 Week Low price of ₹273.6
| Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM | Returns |
|---|---|
1 Day Returns | -41.6% |
1 Month Returns | -12.94% |
3 Month Returns | 54.39% |
1 Year Returns | 62.41% |